Valuation (17%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -31.73 | N/A |
| PEG Ratio (TTM) | -0.01 | N/A |
| P/S Ratio (TTM) | 8.88 | N/A |
| P/B Ratio (TTM) | 1.74 | N/A |
| P/FCF Ratio (TTM) | 296.42 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -5.47% | N/A |
| ROE (TTM) | -10.98% | N/A |
| Net Profit Margin (TTM) | -27.97% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 873.25% | N/A | N/A |
| Revenue | 506.35% | N/A | N/A |
| Net Income | -149.70% | N/A | N/A |
| Cash Flow | -19.19% | N/A | N/A |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.05 | N/A |
| Quick Ratio (TTM) | 4.05 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | -4.53 | N/A |
| Piotroski F-Score | 2 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |